Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.
about
Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical TransmissionAntibody Engineering for Pursuing a Healthier FutureRecent Advances in the Analysis of Single Cells.Deterministic Migration-Based Separation of White Blood Cells.Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study.Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
P2860
Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Utility of the Enzyme-Linked I ...... ic Cell Transplant Recipients.
@en
type
label
Utility of the Enzyme-Linked I ...... ic Cell Transplant Recipients.
@en
prefLabel
Utility of the Enzyme-Linked I ...... ic Cell Transplant Recipients.
@en
P2093
P2860
P356
P1476
Utility of the Enzyme-Linked I ...... ic Cell Transplant Recipients.
@en
P2093
Elizabeth J Shpall
Ella J Ariza-Heredia
George Makedonas
Hala K Siddiqui
Jacques M Azzi
Katy Rezvani
Lamprinos Michailidis
Lisa Y Marsh
Roy F Chemaly
Shasank S Ghantoji
P2860
P304
P356
10.1093/INFDIS/JIW064
P407
P577
2016-02-11T00:00:00Z